110亿，强生爽身粉致癌案判了

Core Viewpoint - Johnson & Johnson faces significant legal challenges and financial liabilities due to claims that its baby powder products contain asbestos, leading to cancer diagnoses among users, with a recent jury awarding $1.56 billion in damages to a plaintiff [1][4]. Group 1: Legal Challenges and Financial Liabilities - A Maryland jury ruled that Johnson & Johnson must pay approximately $1.56 billion to a woman who developed mesothelioma after using its baby powder, marking the highest compensation awarded to a single plaintiff in the company's history [1]. - The company has faced multiple lawsuits over the years, with previous rulings including $72 million in 2016 for an ovarian cancer patient and $417 million in 2017 for another plaintiff [2]. - Johnson & Johnson's subsidiary, Red River Talc, filed for prepackaged bankruptcy in 2024 to address ongoing litigation related to talc claims, proposing a settlement plan worth approximately $8 billion over 25 years [4]. Group 2: Product Safety and Corporate Actions - Johnson & Johnson has historically denied that its products contain asbestos, asserting that extensive testing confirms their safety [2]. - In response to declining sales due to the cancer allegations, the company ceased production of talc-based baby powder in the U.S. and Canada in 2020, later expanding this decision globally in 2023 [3]. - The company has attempted to mitigate litigation risks through settlements, including a $8.9 billion agreement to resolve claims over 25 years and a $700 million settlement with 42 states in 2024 [4]. Group 3: Industry Implications - The ongoing legal battles and substantial financial penalties serve as a warning to global companies about the consequences of prioritizing commercial interests over public health [5]. - The situation highlights the potential risks associated with product safety and the importance of transparency in corporate practices [5].